News

NYAS Meeting on TB – April 6, 2010


22 Mar 2010
by Working Group

nyas logo
NYAS

In more than 10 years since the sequence of the Mycobacterium tuberculosis genome was published, the genetic information of the pathogen and genetic tools have shifted the emphasis of TB drug research. This symposium highlights how they are utilized in the quest for novel TB regimens.

This meeting will be presented by the Emerging Infectious Diseases and Microbiology Discussion Group at the New York Academy of Sciences.

Speakers include:

  • Helen Boshoff (NIH)
  • William R. Jacobs, JR. (Albert Einstein college of Medicine)
  • Carl Nathan (Weill Cornell Medical College)
  • Christopher Sassetti (University of Massachusetts Medical School)
  • Dirk Schnappinger (Weill Cornell Medical College)

The meeting is organized by Takushi Kaneko (TB Alliance) and Jennifer Henry (NYAS).

For more information and to register, please visit www.nyas.org/TB. An online webinar is also available if you are unable to attend in person.

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...